SCHEMBL20101186

SCHEMBL20101186

PNCCc1ncc2ccccc2c1-c1ccccc1

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
AKT1 P31749 1/20 0.38
KDM4E B2RXH2 3/20 0.35
GPR3 P46089 1/20 0.35
ESR1 P03372 2/20 0.33
ESR2 Q92731 2/20 0.33
CYP11B1 P15538 1/20 0.33
CYP11B2 P19099 1/20 0.33
LMNA P02545 3/20 0.33
MAPT P10636 3/20 0.33
NPC1 O15118 2/20 0.33
RECQL P46063 1/20 0.33
RAB9A P51151 1/20 0.33
SMN1; SMN2 Q16637 1/20 0.33
PDE5A O76074 1/20 0.31
HPGD P15428 2/20 0.31
MEN1 O00255 1/20 0.31
KMT2A Q03164 1/20 0.31
TDP1 Q9NUW8 3/20 0.31
CTDSP1 Q9GZU7 1/20 0.31
ALDH1A1 P00352 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22333840 0.76 DHFR (0.46) AKT1KDM4EGPR3ESR1ESR2
SCHEMBL16624730 0.73 SMN1; SMN2 (0.48) AKT1KDM4ELMNAMAPTNPC1
SCHEMBL2730235 0.72 PDE10A (0.48) KDM4ELMNAMAPTNPC1RAB9A
SCHEMBL2717723 0.72 PIK3CD (0.43) KDM4ESMN1; SMN2HPGDALDH1A1CYP3A4
SCHEMBL11541098 0.70 AKT1 (0.37) AKT1KDM4EGPR3ESR1ESR2
SCHEMBL29576853 0.69 AKT1 (0.64) AKT1KDM4EGPR3ESR1ESR2
SCHEMBL913394 0.69 AKT1 (0.64) AKT1KDM4EGPR3ESR1ESR2
SCHEMBL18648904 0.69 AKT1 (0.46) AKT1KDM4EGPR3ESR1ESR2
SCHEMBL20799451 0.68 HPGD (0.46) KDM4EMAPTHPGDMEN1KMT2A
SCHEMBL21610293 0.68 TDP1 (0.43) AKT1KDM4ELMNAMAPTNPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3052107-B1 ORGANIC COMPOUNDS TO TREAT HEPATITIS B VIRUS NOVARTIS AG (CH) 2018-05-02 EP disclosed